DCF Advisers, LLC 13F Portfolio

CIK 1802493 Filing since Q4 2019 Q3 2026 filed Nov 4, 2026
Holdings as of Sep 30, 2026, from the 13F filed Nov 4, 2026.

Portfolio Snapshot

82 positions · Q3 2026

DCF Advisers, LLC reported 82 positions worth $309.88M for the quarter ended Sep 30, 2026, down 15.0% on the prior quarter. It opened 11 new positions, added to 23, trimmed 28 and exited 1. Its largest holding is Micron Technology Inc at 22.7% of the portfolio.

Portfolio Value
$309.88M
-15.0% QoQ · +52.3% YoY
Positions
82
11 new · 1 sold out
Top 10 Concentration
56.4%
of portfolio value
Largest Position
MU 22.7%
Micron Technology Inc
Net Buying
-$48.77M
$21.59M bought · $70.36M sold
Turnover
6.4%
of the portfolio traded
Top Sector
Technology
50.4% of value
Track Record
28
quarters on file since Q4 2019

Portfolio Value & Positions

Value Positions

Reported 13F market value at each quarter end. A change mixes trading with price moves in the positions held.

Sector Allocation

9 sectors
50.37%
Technology
Technology50.37%
Healthcare27.53%
Other9.01%
Consumer Discretionary5.66%
Financial Services3.64%
Energy1.92%
Basic Materials1.22%
Industrials0.518%
Consumer Staples0.142%

Quarterly Buying & Selling

Bought Sold

Dollar value of shares bought and sold each quarter, at that quarter’s price. It counts trading only, not price changes.

Position Changes

How many positions were opened, added to, trimmed or closed each quarter.

Sector Allocation Over Time

Share of reported value in each sector at every quarter end.

TechnologyHealthcareOtherConsumer DiscretionaryFinancial ServicesEnergyBasic MaterialsIndustrialsConsumer StaplesCommunication Services

Largest Buys

Q3 2026
Holding Change Change % Trade Value Weight
SNY Sanofi +75.0K – $3.09M 0.998%
SVRA Savara Inc +570.0K +570.0% $2.94M 1.12%
VRTX Vertex Pharmaceuticals Inc / Ma +3,650 +31.7% $1.91M 2.56%
AZN Astrazeneca Plc +9,250 +194.7% $1.49M 0.729%
IFRX InflaRx N.V. +746.5K +326.7% $1.34M 0.566%
MDT Medtronic plc +14.5K +483.3% $1.25M 0.487%
IBIT iShares Bitcoin Trust ETF +20.0K – $946.80K 0.306%
META Meta Platforms, Inc. +1,000 +50.0% $725.18K 0.702%
MRVL Marvell Technology, Inc. +2,500 +9.1% $660.53K 2.56%
PINS Pinterest, Inc. +30.0K +75.0% $566.70K 0.427%

Largest Sells

Q3 2026
Holding Change Change % Trade Value Weight
MU Micron Technology Inc -34.0K -34.0% $36.21M 22.69%
TEVA Teva Pharmaceutical Industries Ltd -254.5K -100.0% $8.62M Exited
HELP Helus Pharma Inc. -432.4K -30.1% $5.31M 3.98%
CSCO Cisco Systems, Inc. -26.5K -66.3% $2.85M 0.469%
HZO Marinemax Inc -50.0K -87.0% $2.62M 0.127%
INTC Intel Corp -20.0K -70.2% $2.40M 0.33%
ARGX Argenx Se -2,500 -17.6% $2.40M 3.62%
REGN Regeneron Pharmaceuticals, Inc. -2,200 -23.8% $1.67M 1.73%
MSFT Microsoft Corp -3,225 -33.2% $1.65M 1.08%
AMZN Amazon Com Inc -4,250 -7.2% $1.06M 4.42%

New Positions

Q3 2026
Holding Shares Trade Value Weight
SNY Sanofi +75.0K $3.09M 0.998%
IBIT iShares Bitcoin Trust ETF +20.0K $946.80K 0.306%
IBM International Business Machines Corp +2,500 $549.83K 0.177%
GMAB Genmab A/S +15.0K $535.13K 0.173%
ICUI Icu Medical Inc +3,225 $517.65K 0.167%
SBUX Starbucks Corp +5,000 $469.80K 0.152%
INSM INSMED Inc +4,000 $456.56K 0.147%
NN Nextnav Inc. +26.8K $384.67K 0.124%
EIKN Eikon Therapeutics, Inc. +33.8K $271.69K 0.088%
QTTB Q32 Bio Inc. +13.0K $107.51K 0.035%

Closed Positions

Q3 2026
Holding Shares Sold Trade Value Prior Weight
TEVA Teva Pharmaceutical Industries Ltd -254.5K $8.62M 2.36%
Holdings · Q3 2026

82 Positions

As ofSep 30, 2026
Value$309.88M
Top 1056.4%
Avg position$3.78M
# Activity
67 more holdings Create a free account to keep reading this institution’s full portfolio.
Showing 1–15 of 82 positions 13F filings on SEC EDGAR

Tip. Select a row to see that position’s full history at DCF Advisers.

About DCF Advisers, LLC’s 13F Portfolio

What are DCF Advisers, LLC’s largest holdings?

As of its Q3 2026 13F filing, DCF Advisers, LLC’s five largest positions were Micron Technology Inc (MU) at 22.7%, Alphabet Inc. (GOOG) at 5.9%, Advanced Micro Devices Inc (AMD) at 5.7%, Amazon Com Inc (AMZN) at 4.4%, Helus Pharma Inc. (HELP) at 4.0% of the reported portfolio.

How much is DCF Advisers, LLC’s portfolio worth?

DCF Advisers, LLC reported a 13F portfolio worth $309.88M across 82 positions for Q3 2026. That is down 15.0% from the previous quarter.

What did DCF Advisers, LLC buy in Q3 2026?

Its largest purchases by value were Sanofi ($3.09M), Savara Inc ($2.94M), Vertex Pharmaceuticals Inc / Ma ($1.91M). It opened 11 new positions.

What did DCF Advisers, LLC sell in Q3 2026?

Its largest sales by value were Micron Technology Inc ($36.21M), Teva Pharmaceutical Industries Ltd ($8.62M), Helus Pharma Inc. ($5.31M). It exited 1 positions entirely.

Where does this data come from?

From the Form 13F-HR reports DCF Advisers, LLC files with the SEC each quarter, within 45 days of quarter end. A 13F lists long positions in US-listed equities and options; it excludes short positions, cash, bonds and most non-US holdings.

Similar-Sized Institutions

by reported 13F value

13F data reflects long positions in US-listed equities and options as reported to the SEC up to 45 days after quarter end. It excludes short positions, cash, bonds and most non-US securities, so it is not a complete picture of a manager’s assets.